Tenderwize
Back to tender search

Germany – Pharmaceutical products – Aufhebung der nicht-exklusiven Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: [email protected] Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/Eschborn, GermanyNot disclosed142 days leftopen
5

Opportunity Score

Confidence: 30%

Complexity: low

142 days

Deadline

supplies

Contract

Deep Portfolio Analysis

  • Company fit score
  • Missing certificates
  • Eligibility blockers
  • Bid / No-Bid recommendation
Create account for AI analysis

AI Analysis Summary

Not recommended

This is a corrigendum notice canceling the Open House procedure for non-exclusive discount agreements for two active ingredients: Aflibercept (40mg/ml) and Ranibizumab. The cancellation takes effect on 31.07.2026; no new contracts can be concluded after that date. Existing contracts will be terminated. A new publication is expected. Despite the cancellation, the notice includes a submission deadline of 2026-11-04, which is likely erroneous or misleading.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

  • Procedure is cancelled; no new participation is possible.
  • The deadline 2026-11-04 is likely irrelevant or erroneous given the cancellation.

Buyer

Name

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: [email protected] Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/

Location

Eschborn, DEU

Identifier

DE114110216

Lots (2)

#LOT-0001Aflibercept nur in der Wirkstärke 40mg/ml (S01LA05)

Open House procedure for non-exclusive discount agreements for Aflibercept 40mg/ml. The procedure is cancelled effective 31.07.2026; no new contracts can be concluded. Existing contracts terminated.

33600000
#LOT-0002Ranibizumab (S01LA04)

Open House procedure for non-exclusive discount agreements for Ranibizumab. The procedure is cancelled effective 31.07.2026; no new contracts can be concluded. Existing contracts terminated.

33600000

Procurement Details

Publication

14 Jun 2026

Deadline

04 Nov 2026, 11:00

Procedure

open

Contract

supplies

Language

DEU

Publication #

408390-2026

Classification

Documents (1)

Pharmaceutical products Tender in Germany | TED 408390-2026